Circassia Pharmaceuticals PLC  

(Public, LON:CIR)   Watch this stock  
Find more results for Charles L. Cummings
345.00
+2.00 (0.58%)
Sep 2 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 336.24 - 345.00
52 week 246.00 - 345.00
Open 343.00
Vol / Avg. 78,656.00/120,446.00
Mkt cap 981.43M*
P/E     -
Div/yield     -
EPS -0.21*
Shares 284.90M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -3786.41% -
Operating margin -4585.19% -
EBITD margin - -
Return on average assets -11.86% -29.43%
Return on average equity -13.84% -31.81%
Employees 63 -
CDP Score - -

Address

The Magdalen Centre Robert Robinson Avenue The Oxford Science Park
OXFORD, OX4 4GA
United Kingdom - Map
+44-1865-405560 (Phone)
+44-1865-784576 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Circassia Pharmaceuticals plc (Circassia) is a United Kingdom-based specialty biopharmaceutical company focused on the development of immunotherapies. The Company designs immunotherapies to treat a range of common allergies and autoimmune conditions. The Company's treatment, Cat-SPIRE is in the final Phase of testing for cat allergy. Circassia's pipeline of immunotherapies is based on its ToleroMune technology. ToleroMune identifies T cell epitopes, which are short linear stretches of amino acids in allergen sequence; binds to antigen presenting cells to induce regulatory T cells and identified from blood of allergic individuals. The Company also has completed the Phase IIb study for Ragweed-SPIRE, Grass-SPIRE and House Dust Mite (HDM)-SPIRE.

Officers and directors

Francesco Granata M.D. Non-Executive Chairman of the Board
Age: 64
Steven Harris Chief Executive Officer, Executive Director
Age: 48
Julien Cotta Chief Financial Officer, Executive Director
Age: 51
Rod Hafner Senior Vice President - Research & Development, Executive Director
Age: 49
Steve Pawsey Chief Medical Officer
Russell Cummings Non-Executive Director
Age: 50
Paul R. Edick Non-Executive Director
Age: 60
Cathrin Petty Non-Executive Director
Age: 41
Charles Swingland Non-Executive Director
Age: 62
Tim Corn Non-Executive Independent Director
Age: 63